Jong-Hun Im is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of aptamer technology, holding a total of 2 patents. His work focuses on developing methods for identifying aptamers that can bind to specific target molecules, which has important implications in diagnostics and therapeutics.

Latest Patents

Jong-Hun Im's latest patents include innovative methods for aptamer sandwich assays. This invention provides techniques for identifying a plurality of aptamers that bind to different sites of a target molecule. The methods utilize a library of aptamers identified from the same SELEX process. Another significant patent is related to nucleolin-specific aptamers. This patent presents improved G-rich oligonucleotide (GRO) aptamers that are specific to nucleolin, along with methods for preparing these aptamers. The applications of these aptamers are aimed at diagnosing and treating nucleolin-associated diseases.

Career Highlights

Throughout his career, Jong-Hun Im has worked with esteemed organizations such as the Postech Academy-Industry Foundation and Posco. His experience in these institutions has allowed him to further his research and development in aptamer technology.

Collaborations

Jong-Hun Im has collaborated with notable colleagues, including Young-Chan Chae and Youn-Dong Kim. These collaborations have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jong-Hun Im is a prominent figure in the field of aptamer technology, with a focus on innovative methods that have the potential to impact medical diagnostics and treatment. His contributions through his patents reflect his dedication to advancing scientific knowledge and technology.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com